SCHEMBL1720924

SCHEMBL1720924

N[C@H]1CNC[C@]1(Cc1ccccc1)NC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 2/20 0.39
HSD11B1 P28845 1/20 0.34
CTSD P07339 1/20 0.33
MAPK1 P28482 1/20 0.33
EPHX2 P34913 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CYP2D6 P10635 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
JAK3 P52333 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ADRB2 P07550 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18342304 1.00 MC4R (0.39) MC4RHSD11B1CTSDMAPK1EPHX2
SCHEMBL458294 0.83 CA12 (0.39) EPHX2SSTR4KMT2A
SCHEMBL3475585 0.71 ADRB2 (0.36) HSD11B1MAPK1EPHX2MAOAMAOB
SCHEMBL1721157 0.71 SSTR4 (0.36) MC4REPHX2SSTR4
SCHEMBL21359176 0.70 SLC6A4 (0.42) HSD11B1MAPK1MAOAMAOBCYP2D6
SCHEMBL13735783 0.70 ALDH1A1 (0.39) MC4RCYP2D6CYP1A2CYP2C19KDM4E
SCHEMBL16653710 0.70 ALDH1A1 (0.39) MC4RCYP2D6CYP1A2CYP2C19KDM4E
SCHEMBL15880135 0.70 ALDH1A1 (0.39) MC4RCYP2D6CYP1A2CYP2C19KDM4E
SCHEMBL21359111 0.69 ALDH1A1 (0.36) HSD11B1MAPK1EPHX2MAOAMAOB
SCHEMBL2225974 0.66 KDM1A (0.42) MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406256-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103335-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed